课题基金 / 基金详情

Essential Core Activities: NIAID Preclinical Development Support

Essential Core Activities: NIAID Preclinical Development Support
必要的核心活动：NIAID 临床前开发支持
批准号：
9559776
负责人：
THOMAS VANCOTT
金额：
$65.49万
依托单位：
ADVANCED BIOSCIENCE LABORATORIES, INC.
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
项目状态：
已结题
起止时间：
2017-08-29 至 2018-08-28
来源：
https://reporter.nih.gov/project-details/9559776
关键词：
AIDS preventionContractorDevelopmentDocumentationHIV vaccineInvestigational DrugsInvestigator-Initiated ResearchModalityNational Institute of Allergy and Infectious DiseasePhasePreclinical TestingProcessProductionSupport Contractsflexibilitymicrobicidepreclinical developmentresearch clinical testingresearch study

项目摘要

项目成果

THOMAS VANCOTT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
NIAID Preclinical Development Support: This contract will provide NIAID with a broad and flexible range of nontraditional, proactive and developmentally-oriented capabilities to provide preclinical development support for promising products when such products emerge from investigator-initiated research studies. These capabilities will allow NIAID to more rapidly and efficiently close development and production gaps. The Contractor shall assist NIAID staff in providing all support needed for small-scale production, preclinical testing and documentation leading to Investigational New Drug (IND) submission for Phase I, II, and III clinical testing
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Essential Core Activities: NIAID Preclinical Development Support
NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines
ESSENTIAL CORE ACTIVITIES, NIAID PRECLIN DEVELOPMENT SUPPORT
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINS
海外基金